Antonia Gabriella De Souza Freitas

Antonia Gabriella De Souza Freitas

Auto-generated profile, based on publicly available information

Antonia Gabriella De Souza Freitas

Department of Clinical and Toxicological Analysis, Federal University of Ceará, Fortaleza 60430-370, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Journal of Health & Biological Sciences
Verified
Journal Article
Open access
PDF file
MCMac Dionys Rodrigues da Costa
Mac Dionys Rodrigues da Costa
RMRichard Rarison Cavalcante Menezes
Richard Rarison Cavalcante Menezes
ESEderson Laurindo Holanda de Sousa
Ederson Laurindo Holanda de Sousa
CACauan Farias Ananias
Cauan Farias Ananias
MFMateus Oliveira Fernandes
Mateus Oliveira Fernandes
MQMaria Goretti Rodrigues Queiroz
Maria Goretti Rodrigues Queiroz
Objetivo: avaliar o envolvimento do polimorfismo de nucleotídeo único (SNP) rs670 no tamanho das partículas e na ação antioxidante do HDL. Métodos: foram coletados dados socioeconômicos, sociodemográficos e clínicos. Além disso, foram determinados dados antropométricos, perfis glicêmicos e lipídicos, níveis de apolipoproteína A-I e B, níveis de ácidos graxos não esterificados, índice ômega-3, genotipagem do SNP rs670 e subfrações de partículas de HDL e função antioxidante. Resultados: 78 indivíduos, com prevalência de mulheres (46, 59%), idade média de 40 (±14) anos, presença de fatores de risco cardiovascular (n = 72; 92,3%), entre outros. De acordo com o SNP rs670, não foi observada diferença entre os parâmetros sociodemográficos, glicolipídicos, antropométricos e capacidade antioxidante da HDL. No entanto, o genótipo CC mostrou correlações entre o colesterol HDL e a glicemia(rho=-0,304), triglicerídeos (rho=-0,324), índice de massa corporal (rho=-0,439) e circunferência da cintura (rho=-0,516). Os genótipos CT e TT mostraram correlações entre a relação HDL 1-2/9-10 e a glicemia (rho=-0,576) e a relação Apo B/Apo A-I (rho=-0,629). Além disso, a presença do alelo T pode ser prevista pela relação HDL 1-2/9-10. Conclusões: conclui-se que o alelo T polimórfico estava associado a relações HDL mais elevadas em relação às mais baixas, possivelmente afetando sua funcionalidade.

2 January 2026 in Journal of Health & Biological Sciences
Verified
Journal Article
Open access
PDF file
RFRejane Moraes Falcão
Rejane Moraes Falcão
APAna Júlia Batista Pereira
Ana Júlia Batista Pereira
NPNatasha Maria Lima Pinheiro
Natasha Maria Lima Pinheiro
PJPedro Nonato da Silva Júnior
Pedro Nonato da Silva Júnior
ÍMÍtalo Costa Monteiro
Ítalo Costa Monteiro
TSTiago Sampaio
Tiago Sampaio
Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.

6 November 2026 in Revista de Epidemiologia e Controle de Infecção
Verified
Journal Article
Open access
NPNatasha Maria Lima Pinheiro
Natasha Maria Lima Pinheiro
AFAntonia Gabriella de Souza Freitas
Antonia Gabriella de Souza Freitas
DLDiogo Thomas Ferreira de Lima
Diogo Thomas Ferreira de Lima
ÍMÍtalo Costa Monteiro
Ítalo Costa Monteiro
MFMateus Oliveira Fernandes
Mateus Oliveira Fernandes
TSTiago Sampaio
Tiago Sampaio
Background and Objectives: Pseudomonas aeruginosa is an opportunistic pathogen and a major cause of healthcare-associated infections. The World Health Organization (WHO) has identified this pathogen as a critical priority in the context of antimicrobial resistance. Among its resistance mechanisms, the MexAB-OprM efflux pump plays an important role in reducing susceptibility to antimicrobial agents. This integrative review aimed to examine the relationship between the MexAB-OprM efflux pump and antimicrobial resistance in P. aeruginosa, with the broader goal of contributing to the development of effective clinical management strategies. Content: A literature search identified 113 records. Studies were screened based on predefined eligibility criteria. Reviews, meta-analyses, articles for which the full text was unavailable, and studies that did not focus on P. aeruginosa and the MexAB-OprM efflux pump were excluded during the initial screening. In the subsequent stage, studies that did not specifically address the role of this efflux system in antimicrobial resistance were also excluded. Following the selection process, 24 studies were included in the review. The findings indicate that the MexAB-OprM efflux pump contributes to antimicrobial resistance in P. aeruginosa. Moreover, its contribution is not independent of other resistance mechanisms but frequently occurs in conjunction with them, particularly β-lactamase production. Conclusion: MexAB-OprM-mediated resistance poses a significant challenge to the clinical management of infections caused by multidrug-resistant P. aeruginosa, particularly in healthcare settings. Further research into the role of this efflux system, alongside a critical assessment of current treatment protocols, is warranted to improve therapeutic strategies and mitigate the impact of antimicrobial resistance.

1 January 2024
Verified
Book Chapter
Open access
MCMireia De Oliveira Correia
Mireia De Oliveira Correia
AJAfonso Leoncio Saraiva Junior
Afonso Leoncio Saraiva Junior
AFAntonia Gabriella De Souza Freitas
Antonia Gabriella De Souza Freitas
ALAna Caroline Borges Lima
Ana Caroline Borges Lima
TSTiago Sampaio
Tiago Sampaio
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]

1 January 2024
Verified
Book Chapter
Open access
MCMireia De Oliveira Correia
Mireia De Oliveira Correia
AFAna Lívia Neves Ferreira
Ana Lívia Neves Ferreira
AFAntonia Gabriella De Souza Freitas
Antonia Gabriella De Souza Freitas
ALAna Beatriz Silva Lima
Ana Beatriz Silva Lima
TSTiago Sampaio
Tiago Sampaio
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]

9 January 2026 in Exploration of Endocrine and Metabolic Diseases
Verified
Journal Article
Open access
PDF file
CACauan Farias Ananias
Cauan Farias Ananias
MFMateus Oliveira Fernandes
Mateus Oliveira Fernandes
AFAntônia Gabriella de Souza Freitas
Antônia Gabriella de Souza Freitas
SOSarah Maria Guilherme Oliveira
Sarah Maria Guilherme Oliveira
LKLais Maurício Kfuri
Lais Maurício Kfuri
TSTiago Sampaio
Tiago Sampaio
Background: Metabolic syndrome and dyslipidaemia increase the risk of death by two or three times. In this context, the role of apolipoprotein A-I (Apo A-I), the main structural protein of high-density lipoprotein (HDL), stands out, since its anti-inflammatory potential reduces cardiovascular risk. Further, genetic modifications, such as the rs670 single-nucleotide polymorphism (SNP), in the promoter region of the APOA1 gene are associated with the development of cardiovascular events, dyslipidemia, and diabetes, as well as metabolic syndrome. Thus, this study aims to investigate the relation between the occurrence of dyslipidemia and the rs670 SNP genotypes. Methods: An integrative and systematic review was performed with the LitVar2 database according to the PRISMA protocol standards. Studies were researched up to August 2025. Then, a meta-analysis was performed using the fixed-effects model, since the study was considered homogeneous based on the I2 value (< 50%). Results: Of the 99 found articles in the database, 5 referred to metabolic disorders (n = 7,705—4 Chinese studies and 1 Iranian study) and were published between 2015 and 2018. Three (n = 2,784 patients or 36.13%) of the articles indicated an association between the polymorphic allele and a higher risk of developing dyslipidemia with a relative risk of 1.16 (IC 95% 1.09–1.23, p < 0.01, I2 = 0%). Relative risk (IC 95%) was presented, and p < 0.05 was defined as the significance criterion. Discussion: This study reinforces a possible association between the influence of SNP rs670 and dyslipidemia. This emphasizes the importance of conducting further research incorporating a larger and more diverse study group, as well as investigating the genetic and environmental influence on the phenotypic expression of the rs670 SNP.